Unilateral TAP Block vs Trocar Insertion Sites Infiltration Anesthesia in Laparoscopic Cholecystectomy
Launched by DISKAPI YILDIRIM BEYAZIT EDUCATION AND RESEARCH HOSPITAL · May 31, 2018
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
Patients will be randomly allocated by a computer generated random numbers list into three groups. After general anesthesia induction and intubation patients will receive analgesia according to group allocation. In group TAP (Group T) the transversus abdominis plane block will be commenced with ultrasound guidance while the patients is in the supine position with a subcostal approach using 20 mL 0.25% bupivacaine and 21 G block needle. In group infiltration anesthesia (Group I) the trocar insertion sites will be infiltrated with 20 mL 0.25% bupivacaine: 7 mL for the 10 mm trocar insertion s...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Clinical diagnosis of biliary disease
- Exclusion Criteria:
- • Uncooperative patients
- • Blood coagulation disorders
- • Laparatomy
- • Obesity: body mass index \>35
- • Renal failure
- • Hepatic failure
- • Emergency surgery
- • Pregnancy
About Diskapi Yildirim Beyazit Education And Research Hospital
Diskapi Yildirim Beyazit Education and Research Hospital is a prominent healthcare institution dedicated to advancing medical knowledge and patient care through innovative clinical research. Located in Ankara, Turkey, the hospital is committed to providing high-quality education and training for healthcare professionals while facilitating comprehensive clinical trials that adhere to rigorous ethical and scientific standards. As a key player in the region's medical landscape, the hospital collaborates with various stakeholders to explore new therapies and interventions, contributing to the improvement of health outcomes both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Emine Arik, Dr
Principal Investigator
Ministry f Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials